Feature | Breast Density | April 03, 2020 | By Dayna Williams M.D., Shivani Chaudhry, M.D., and Laurie R. Margolies, M.D.

Breast Density Explained

A primer of breast imaging modalities and how to keep patients informed 

Category A

Category A

Category B

Category B

Category C

Category C

Category D

Category D

Breast cancer is the most common cancer in women, and, for women in their forties, the leading cause of premature death. It is the most common cause of death from cancer among Hispanic women, and the second most common cause of death from cancer among white, black, Asian/Pacific islander and American Indian/Alaska native women, according to the Centers for Disease Control and Prevention (excluding non-melanoma skin cancers).1

While there has been some recent controversy regarding mammography screening recommendations, the American College of Radiology (ACR), Society of Breast Imaging (SBI) and American Society of Breast Surgeons (ASBrS) recommend that women with an average risk of breast cancer begin getting annual screening mammograms at age 40,2,3 as this is the only test that has been shown to reduce breast cancer mortality. These are read by radiologists with specialized training in breast imaging. 

Viewing Dense Breast Tissue

Breast tissue is composed of a mixture of milk ducts, glands and supportive tissue, which is collectively called fibroglandular tissue and fat. The radiologist who reviews the mammogram analyzes overall breast density, which is the ratio of the amount of fibroglandular tissue to fatty tissue. Women with dense breasts have more fibroglandular tissue than fatty tissue. Fibroglandular tissue appears white on a mammogram and fat appears black. It becomes harder to detect a white cancer against a white background — imagine trying to find a polar bear in a blizzard. Dense tissue is harder to see through to detect abnormal findings. As breast density increases, cancer detection becomes more difficult. Additionally, breast cancer risk rises with increasing breast density. Multiple studies have indicated that there is a two- to six-fold increased risk of breast cancer for a woman who has an extremely dense breast versus a woman with an almost entirely fatty breast.4

Breast density is divided into four categories, from lowest to highest amounts of fibroglandular tissue composition:

Category A: Almost entirely fatty (least amount of fibroglandular tissue)

Category B: Scattered fibroglandular tissue

Category C: Heterogeneously dense

Category D: Extremely dense (most amount of fibroglandular tissue)

 

Mammography has an overall sensitivity of 70-90 percent, which is variable, ranging from as low as 30-48 percent in patients with dense breasts to as high as 80-98 percent in patients with fatty breasts.5 

Connecticut was the first state to mandate that radiologists inform all women undergoing screening mammography if they have dense breast tissue. Mammography facilities will soon be required by federal regulations to include breast density information in reports sent to patients and their physicians. 

The U.S. Food and Drug Administration (FDA) is creating standard reporting language; mammography reports and summaries must include, at a minimum, the following information:

1. How breast density may mask cancer on a mammogram.

2. A qualitative assessment of breast density as performed by the reader.

3. A reminder to individuals with dense breasts to talk with their provider if they
have questions.

Screening Ultrasound for Women at Risk

Screening breast ultrasound has been demonstrated to be an effective supplemental screening option, along with mammography, in women with dense breasts. Studies show that screening ultrasound can increase breast cancer detection rates.6 This is due to the fact that dense breast tissue appears whiter on ultrasound, but cancers generally appear darker (unlike mammography). Often, if a woman has heterogeneously dense or extremely dense breasts, the reporting radiologist will recommend supplemental screening with breast ultrasound. 

Digital breast tomosynthesis (DBT) has been shown to increase cancer detection rates compared to full field digital mammograms (FFDM) irrespective of tumor type, size or grade of cancer.7 Cancers that might have remained hidden on FFDM behind overlapping dense tissue are better seen on DBT.

Depending on a patient’s lifetime risk for breast cancer, supplemental screening with breast magnetic resonance imaging (MRI) may be recommended. Recent research has indicated that screening with abbreviated breast MRI resulted in the detection of 15.2 cancers per 1,000 women versus 6.2 cancers per 1,000 women screened with digital breast tomosynthesis alone in women with dense breasts. In June 2016, New York became the first state to mandate full insurance coverage without co-pays for all screening breast imaging exams including supplemental imaging (such as breast MRI and ultrasound) for women with dense breasts.8

Best Tools of Detection

As breast imagers, our three most common tools of detection are mammography, breast ultrasound and breast MRI, which Mount Sinai Hospital uses in conjunction with the patient’s clinical history and physical exam. Early detection and treatment are the most important ways to prevent deaths from breast cancer. It is easier to successfully treat breast cancer that is detected early, when it is at a smaller size and has not spread. Regular screening tests are the most reliable method for early detection and result in decreased cancer stage at diagnosis and less need for more extensive treatment.9 Equipping women with knowledge of their breast density and personal breast cancer lifetime risk allows them to make informed decisions regarding their own most effective personalized screening regimen.

Dayna Williams, M.D., is an assistant professor of radiology in breast imaging at Mount Sinai Hospital in New York, N.Y. She completed a fellowship in breast and body imaging at
Weill Cornell.

Shivani Chaudhry, M.D., is an assistant
professor of radiology in breast imaging at Mount Sinai Hospital in New York, N.Y. She completed
fellowships in women’s imaging at the University of Toronto and breast imaging
at Mount Sinai Hospital.

Laurie R Margolies, M.D., is the director of breast imaging at Mount Sinai Hospital in New York, N.Y. She is a fellow of the American College of Radiology, and was president of the New York Breast Imaging Society.

 

References:

1. https://www.cdc.gov/cancer/breast/statistics/index.htm. Accessed March 17, 2020.

2. https://www.acraccreditation.org/mammography-saves-lives/guidelines. Accessed March 17, 2020.

3. https://www.breastcancer.org/research-news/asbrs-issues-updated-screening-guidelines. Accessed March 17, 2020.

4. McCormack V, Silva I. Breast Density and Parencymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis. Cancer Epidemiol Prev 2006; 15(6). June 2006.

5. Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology 2012 Oct;265(1): 59-69.

6. Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–1404. doi:10.1001/jama.2012.388.

7. https://www.sciencedaily.com/releases/2019/10/191016153705.htm

8. Comstock CE, Gatsonis C, Newstead GM, et al. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening. JAMA. 2020;323(8):746–756. doi:10.1001/jama.2020.0572.

9. Ahn, S., Wooster, M., Valente, C. et al. Impact of Screening Mammography on Treatment in Women Diagnosed with Breast Cancer. Ann Surg Oncol 25, 2979–2986 (2018). https://doi.org/10.1245/s10434-018-6646-8.

Related Content

AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
Phone call and linkage-to-care-based intervention increases mammography uptake among primary care patients at an urban safety-net hospital

Getty Images

News | Mammography | May 22, 2020
May 22, 2020 — Telephone outreach coupled with scheduling assistance significantly increased...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur
Podcast: Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano

Kubtec hosts a Podcast: Impact of COVID-19 on Breast Cancer Treatment with Andrea Madrigrano, M.D., as part of its public service campaign.

News | Coronavirus (COVID-19) | May 06, 2020
May 6, 2020 — The COVID-19 pandemic is an unprec
The American Society of Breast Surgeons (ASBrS), the National Accreditation Program for Breast Centers (NAPBC), the National Comprehensive Cancer Network (NCCN), the Commission on Cancer (CoC) of the American College of Surgeons, and the American College of Radiology (ACR) have released new joint recommendations for prioritization, treatment and triage of breast cancer patients during the coronavirus (COVID-19) pandemic

Getty Images

News | Breast Imaging | April 13, 2020
April 13, 2020 — The American Society of Breast Surgeons (...
Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Sponsored Content | Case Study | Artificial Intelligence | April 09, 2020
As the largest independent imaging group in Michigan with 10 locations across the state,...
Figure 1. R MLO view from four different years. The skin mole is marked with a circular skin marker (TomoSPOT REF# 782, Beekley Medical) on the far-left image. These images demonstrate the potential for significant variability in location of the skin lesion due to movability of the skin during positioning.

Figure 1. R MLO view from four different years. The skin mole is marked with a circular skin marker (TomoSPOT REF# 782, Beekley Medical) on the far-left image. These images demonstrate the potential for significant variability in location of the skin lesion due to movability of the skin during positioning. 

Sponsored Content | Case Study | Breast Imaging | April 09, 2020
Christina Jacobs, M.D., Director of Breast Imaging (...